IMMUNOACTIVATOR, VACCINE ADJUVANT, AND METHOD FOR INDUCING IMMUNITY
In order to provide an immunoactivator capable of enhancing both humoral immunity and cellular immunity, the active ingredient of the immunoactivator being derived from cell walls (derived from a natural product), to provide a vaccine adjuvant, and to provide a method for inducing immunity, the method having a step for administering the immunoactivator, an immunoactivator according to the present invention has particles having a maximum diameter within the range of 1-800 nm as the active ingredient, the particles being composed of cell-wall-derived polysaccharides..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Europäisches Patentamt - (2023) vom: 02. Nov. Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
SUZUKI RYO [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-11-02, Last update posted on www.tib.eu: 2024-03-07, Last updated: 2024-03-08 |
---|
Patentnummer: |
WO2023210722 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA018580130 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA018580130 | ||
003 | DE-627 | ||
005 | 20240308101040.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231124s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA018580130 | ||
035 | |a (EPA)WO2023210722 | ||
035 | |a (EPA)88519101 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a SUZUKI RYO |e verfasserin |4 aut | |
245 | 1 | 0 | |a IMMUNOACTIVATOR, VACCINE ADJUVANT, AND METHOD FOR INDUCING IMMUNITY |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2023-11-02, Last update posted on www.tib.eu: 2024-03-07, Last updated: 2024-03-08 | ||
520 | |a In order to provide an immunoactivator capable of enhancing both humoral immunity and cellular immunity, the active ingredient of the immunoactivator being derived from cell walls (derived from a natural product), to provide a vaccine adjuvant, and to provide a method for inducing immunity, the method having a step for administering the immunoactivator, an immunoactivator according to the present invention has particles having a maximum diameter within the range of 1-800 nm as the active ingredient, the particles being composed of cell-wall-derived polysaccharides. | ||
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a OMATA DAIKI |4 aut | |
700 | 0 | |a MUNAKATA LISA |4 aut | |
700 | 0 | |a SUZUKI YUNO |4 aut | |
700 | 0 | |a KOIZUMI KEIICHI |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 02. Nov. |
773 | 1 | 8 | |g year:2023 |g day:02 |g month:11 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/88519101/publication/WO2023210722A1?q=WO2023210722 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
951 | |a AR | ||
952 | |j 2023 |b 02 |c 11 |